Netherlands - Sold Production of Medicaments of Alkaloids or Derivatives Thereof Packaged for Retail Sale
Since 2010, Netherlands Sold Production of Medicaments of Alkaloids or Derivatives Thereof Packaged for Retail Sale was down by 38.7% year on year. In 2015, the country was number 16 among other countries in Sold Production of Medicaments of Alkaloids or Derivatives Thereof Packaged for Retail Sale at €482,000. Netherlands is overtaken by Estonia, which was ranked number 15 at €618,233 and is followed by Lithuania with €145,972. Germany lead the ranking with €2,350,575,277.14 in 2019, a fall of 3.4% versus 2018. United Kingdom, Poland and Hungary respectively ranked number 2, 3 and 4 in this ranking. Estonia recorded the best 5 years average growth at +11.1% per year, while Netherlands recorded the worst performance at -38.7% per year.
Loading...
Date | Euros |
---|---|
2015 | 482,000.00 |
2014 | |
2013 | |
2012 | 8,103,000.00 |
2011 |
How does Netherlands rank in Sold Production of Medicaments of Alkaloids or Derivatives Thereof Packaged for Retail Sale?
# | 17 Countries | Euros | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Germany
|
2,350,575,277.14 | 2019 | -3.4 % | +8.0 % | View data | |
2 |
#2
United Kingdom
|
195,933,082.68 | 2019 | +2.5 % | -5.9 % | View data | |
15 |
#15
Estonia
|
618,233.00 | 2019 | +32.1 % | +11.1 % | View data | |
16 |
#16
Netherlands
|
482,000.00 | 2015 | NA | -38.7 % | View data | |
17 |
#17
Lithuania
|
145,972.00 | 2019 | -1.4 % | -24.6 % | View data |